Maravai LifeSciences Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Maravai LifeSciences Holdings has a total shareholder equity of $892.3M and total debt of $614.7M, which brings its debt-to-equity ratio to 68.9%. Its total assets and total liabilities are $2.3B and $1.4B respectively.
Key information
68.9%
Debt to equity ratio
US$614.68m
Debt
Interest coverage ratio | n/a |
Cash | US$579.61m |
Equity | US$892.28m |
Total liabilities | US$1.38b |
Total assets | US$2.27b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MRVI *'s short term assets ($700.9M) exceed its short term liabilities ($78.3M).
Long Term Liabilities: MRVI *'s short term assets ($700.9M) do not cover its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: MRVI *'s net debt to equity ratio (3.9%) is considered satisfactory.
Reducing Debt: MRVI *'s debt to equity ratio has reduced from 228.4% to 68.9% over the past 5 years.
Debt Coverage: MRVI *'s debt is well covered by operating cash flow (35.4%).
Interest Coverage: Insufficient data to determine if MRVI *'s interest payments on its debt are well covered by EBIT.